Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

Avai Bio (AVAI) Equity Average (2018 - 2023)

Avai Bio's Equity Average history spans 5 years, with the latest figure at -$1.2 million for Q4 2023.

  • For Q4 2023, Equity Average fell 149.37% year-over-year to -$1.2 million; the TTM value through Dec 2023 reached -$1.2 million, down 149.37%, while the annual FY2020 figure was -$43649.0, N/A changed from the prior year.
  • Equity Average for Q4 2023 was -$1.2 million at Avai Bio, down from -$992541.5 in the prior quarter.
  • Across five years, Equity Average topped out at $43309.0 in Q3 2020 and bottomed at -$1.2 million in Q4 2023.
  • The 4-year median for Equity Average is -$387070.5 (2022), against an average of -$399784.3.
  • The largest annual shift saw Equity Average tumbled 4456.1% in 2019 before it skyrocketed 140.48% in 2020.
  • A 4-year view of Equity Average shows it stood at -$106994.5 in 2019, then decreased by 21.92% to -$130448.5 in 2020, then tumbled by 267.7% to -$479653.5 in 2022, then tumbled by 149.37% to -$1.2 million in 2023.
  • Per Business Quant, the three most recent readings for AVAI's Equity Average are -$1.2 million (Q4 2023), -$992541.5 (Q3 2023), and -$813520.0 (Q2 2023).